Page 1112 - Cote clinical veterinary advisor dogs and cats 4th
P. 1112

554   Interstitial Lung Diseases


           •  Respiratory distress            •  Pneumonia (infectious, aspiration, foreign    TREATMENT
                                                body)
           •  Exercise intolerance            •  Neoplasia                       Treatment Overview
  VetBooks.ir  Nonrespiratory signs:          •  Pulmonary thromboembolism       Treatment consists of removing or addressing
           •  Hemoptysis
                                              •  Cardiogenic or non-cardiogenic pulmonary
           •  Fever
                                                                                 the inciting cause if it can be identified. If
                                                edema
           •  Lethargy
           •  Anorexia                        •  Pleural effusion or pneumothorax  no underlying cause can be identified, treat-
                                                                                 ment is focused on decreasing inflammation.
           •  Weight loss                     Radiographic:                      No treatments are known to directly halt the
           •  Syncope (associated with pulmonary hyper-  •  Infectious pneumonia (bacterial, fungal, viral,   progression of fibrosis.
            tension [PH] or intermittent hypoxemia)  protozoal, parasitic)
                                              •  Noncardiogenic pulmonary edema  Acute General Treatment
           PHYSICAL EXAM FINDINGS             •  Neoplasia                       Oxygen supplementation is indicated for
           •  Spontaneous or elicited cough (productive                          hypoxemic patients in respiratory distress
            or nonproductive)                 Initial Database                   (p. 1146). Many affected patients are comfort-
           •  Pulmonary crackles on auscultation (inspira-  •  CBC               able with mild to moderate chronic arterial
            tory, with pulmonary fibrosis)      ○   ± Inflammatory leukogram ± polycythemia   hypoxemia.
           •  Increased  respiratory  rate  and/or  effort   if chronic hypoxemia
            (inspiratory and expiratory)        ○   Eosinophilia present in 50%-60% of dogs   Chronic Treatment
           •  Right-sided systolic heart murmur may be   with eosinophilic pneumonia  •  Remove potential inciting causes.
            ausculted if PH is present (with tricuspid   •  Thoracic radiographs   ○   Consider discontinuation of any drug
            regurgitation).                     ○   Interstitial, alveolar (severe disease), or   not immediately critical for the patient’s
            ○   Unlike primary heart disease, tachycardia   bronchointerstitial patterns  health.
              is absent, may have sinus arrhythmia  ○   Interstitial nodules     •  Eosinophilic pneumonias: treat underlying
           •  Fever                             ○   Hypoinflation                  cause (e.g., heartworm, other parasites,
           •  Poor body condition               ○   ± Hilar lymphadenopathy        fungi) if identified. If none found, treat with
           •  ± Cyanosis                        ○   ± Right-sided cardiomegaly from cor   immunosuppressive doses of glucocorticoids.
                                                  pulmonale                        ○   Oral glucocorticoids are preferred for dogs
           Etiology and Pathophysiology       •  Arterial blood gas or pulse oximetry  > 10 kg. Inhaled glucocorticoid therapy
           •  ILDs result from injury to alveolar epithelial   ○   ± Hypoxemia       (fluticasone) may be effective in small dogs
            cells and a cycle of inflammation and repara-  ○   ± Hypocarbia          and  can  reduce  systemic  side  effects  of
            tive responses that proceed unchecked.  •  Six-minute walk test may provide an objective   long-term oral glucocorticoids (p. 298).
            ○   In humans, injury can be triggered by  assessment of exercise tolerance.  •  If  present,  PH  may  be  addressed  with
                 Inhalation of toxins, irritants, or   •  Fecal flotation or sedimentation (Baermann):   sildenafil 1-2 mg/kg PO q 12h.
              ■
                allergens                       respiratory parasites            •  For most other ILDs, immunosuppression
                 Vascular damage from drugs   •  Infectious disease testing for agents endemic   has  been  advocated  (provided  infection
              ■
                 Collagen-related vascular diseases  to patient’s geographic region  is definitively ruled out), starting with
              ■
                 Systemic immune-mediated diseases                                 glucocorticoids (e.g., prednisone 2 mg/kg
              ■
                 Infection                    Advanced or Confirmatory Testing     PO q 24h).
              ■
                 Neoplasia                    •  CT provides more specific information on   ○   Empirically  (i.e., without scientific
              ■
            ○   Many veterinary cases are idiopathic.  the extent, pattern, and location of disease.   evidence of their efficacy), other immu-
           •  Alveolar epithelial cell injury leads to  A ground-glass pattern is a common CT   nosuppressive drugs  have been  tried  in
            ○   Inflammatory cell influx        characteristic  for  dogs  with  pulmonary   refractory cases.
            ○   Release of proinflammatory and fibrogenic   fibrosis.
              mediators                       •  Bronchoscopy,  bronchoalveolar  lavage  (p.   Behavior/Exercise
            ○   Deposition of extracellular matrix  1074), and fine-needle aspiration (p. 1113)   Minimize exposure to inhalant fumes, chemi-
            ○   Structural changes, including fibrosis  for cytologic evaluation and culture can   cals, dusts, or other known disease triggers.
           •  Idiopathic pulmonary fibrosis appears to be   provide evidence of underlying infection or
            a fibroproliferative disorder that originates   neoplasia  if  microorganisms  or  neoplastic   Possible Complications
            independently of inflammation (i.e., inflam-  cells are identified:  •  Decompensation during and after bronchos-
            mation is secondary).               ○   Nonspecific inflammatory cells or poor   copy or lung biopsy, especially in patients
            ○   Injured alveolar epithelial cells are still critical   cellularity is seen with ILDs.  with a significant degree of respiratory
              for triggering and sustaining fibrogenesis.  ○   Absence of microorganisms or neoplastic   compromise at rest
                                                  cells does not rule out these causes of   •  Immunosuppression  can  predispose  to
            DIAGNOSIS                             respiratory disease.             secondary infections.
                                              •  Lung biopsy is the only definitive means for   ○   After lung biopsy, allow the incision to
           Diagnostic Overview                  diagnosis.                           heal before administering immunosup-
           Diagnosis is suspected in patients with clini-  ○   Can be performed by a keyhole technique,   pressive medication.
           cal signs and imaging features (radiographic,   thoracoscopy, or thoracotomy  •  These  patients  may  be  predisposed  to
           CT) consistent with ILD in which there is   ○   Special stains are indicated to rule out   pneumonia due to compromise of normal
           no evidence of infectious or neoplastic causes   infectious agents.     respiratory defense mechanisms.
           of respiratory disease. A definitive diagnosis   •  Echocardiogram (p. 1094) to evaluate for
           requires lung biopsy for histopathologic exam.  PH, if indicated.     Recommended Monitoring
                                              •  Various serum and bronchoalveolar lavage   •  Clinical signs
           Differential Diagnosis               fluid biomarkers (e.g.; endothelin-1, CCLX,   •  Periodic physical exam, arterial blood gas (if
           Physical exam (cough/respiratory distress):  CXCL8) have shown promise in a research   significant respiratory compromise), thoracic
           •  Other airway diseases (e.g., chronic bron-  setting to aid in the diagnosis of idiopathic   radiographs, 6-minute walk test
            chitis, eosinophilic bronchitis, obstructive   pulmonary fibrosis.   •  Echocardiogram  (if  indicated  to  monitor
            airway diseases)                                                       PH)

                                                     www.ExpertConsult.com
   1107   1108   1109   1110   1111   1112   1113   1114   1115   1116   1117